Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)

SHA:603590 Revenue

Beijing Konruns Pharmaceutical had revenue of 177.42M CNY in the quarter ending September 30, 2026, a decrease of -23.31%. This brings the company's total for the last twelve months to 863.12M, down -0.94% year-over-year. In the year 2025, Beijing Konruns Pharmaceutical had annual revenue of 915.12M with 10.87% growth. That makes Beijing Konruns Pharmaceutical the 20,742nd largest company in the world by revenue and 3,811th in China.

• Revenue (ttm): 863.12M
• Revenue Growth: -0.94%
• P/S Ratio: 4.71
• Revenue / Employee: 1.09M
• Employees: 793
• Market Cap: 4.06B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• East China 309.31M 33.8%
• North China 244.71M 26.8%
• Southwest Region 99.73M 10.9%
• Central China 94.83M 10.4%
• Southern China 92.44M 10.1%
• North-West Region 44.52M 4.9%
• North-East Area 18.51M 2.0%
• Overseas Areas 10.18M 1.1%

Fiscal year ended Dec 31, 2025 See the full SHA:603590 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	915.12M	89.73M	10.87%
Dec 31, 2024	825.40M	-94.61M	-10.28%
Dec 31, 2023	920.01M	53.29M	6.15%
Dec 31, 2022	866.73M	56.94M	7.03%
Dec 31, 2021	809.78M	1.14M	0.14%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error